“Novel life forms designed using genetic engineering have spawned a host of ethical concerns since 1973. By the early 1980s, the possible commercialization of genetic techniques and the resulting novel organisms led to legal concerns as scientists and companies were seeking patents. This book discusses how genetic engineering affected the patent process and continues to push the definition of what can be patented. The book begins with descriptions of how the American and European patent systems differ in their philosophies for awarding patents. This contrast is important for understanding how patents encounter political concerns when genetic engineering products and technologies are globally marketed. Much of the difference has to do with a government’s viewpoint on valuing corporate growth or protecting public interests. The book then introduces the philosophical concerns about patenting novel life-forms. In the latter chapters, other ethical issues and moral concerns are raised related to animal dignity, human stem cells, and novel life-forms.... Unbiased and accurate assessments are applied in each chapter. The author concludes the book with a proposition for an objective model for setting up equitable life-form patents. This is an excellent book for biotechnology and business law library collections. Highly recommended.”